Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Atezolizumab
Related studies linked through entity extraction aliases.
Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
- Status
- SUSPENDED
- Phase
- PHASE2
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...
- Status
- RECRUITING
- Phase
- PHASE2
Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
- Status
- RECRUITING
- Phase
- PHASE2
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
- Status
- RECRUITING
- Phase
- PHASE1
Atezolizumab in Large Cell Neuroendocrine Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1